Report Detail
Global Pediatric Influenza Treatment Market Growth (Status and Outlook) 2019-2024
- RnM3396432 |
- 08 May, 2019 |
- Global |
- 119 Pages |
- LPI(LP Information) |
- Other
Most kids are enrolled in early education and child care programs. Seasonal influenza outbreaks are expected annually. Influenza can be severe, resulting in hospitalization or death of some children. Immunization against influenza is the best strategy to reduce infection and spread.
According to this study, over the next five years the Pediatric Influenza Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Pediatric Influenza Treatment business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Pediatric Influenza Treatment market by product type, application, key companies and key regions.
This study considers the Pediatric Influenza Treatment value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Antiviral Drug
Antipyretic
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Clinics
Ambulatory Surgical Centers
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc.
NATCO Pharma Limited.
NESHER PHARMS
Johnson & Johnsons Inc.
Cipla
Hetero Pharma
Teva Pharmaceutical pvt. Ltd.
Olainfarm JSC
Gilead Sciences, Inc.
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Pediatric Influenza Treatment market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Pediatric Influenza Treatment market by identifying its various subsegments.
Focuses on the key global Pediatric Influenza Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pediatric Influenza Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Pediatric Influenza Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Pediatric Influenza Treatment Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Pediatric Influenza Treatment Market Size 2014-2024
- 2.1.2 Pediatric Influenza Treatment Market Size CAGR by Region
- 2.2 Pediatric Influenza Treatment Segment by Type
- 2.2.1 Antiviral Drug
- 2.2.2 Antipyretic
- 2.2.3 Neuraminidase inhibitor
- 2.2.4 Others
- 2.3 Pediatric Influenza Treatment Market Size by Type
- 2.3.1 Global Pediatric Influenza Treatment Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Pediatric Influenza Treatment Market Size Growth Rate by Type (2014-2019)
- 2.4 Pediatric Influenza Treatment Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Clinics
- 2.4.3 Ambulatory Surgical Centers
- 2.4.4 Others
- 2.5 Pediatric Influenza Treatment Market Size by Application
- 2.5.1 Global Pediatric Influenza Treatment Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Pediatric Influenza Treatment Market Size Growth Rate by Application (2014-2019)
3 Global Pediatric Influenza Treatment by Players
- 3.1 Global Pediatric Influenza Treatment Market Size Market Share by Players
- 3.1.1 Global Pediatric Influenza Treatment Market Size by Players (2017-2019)
- 3.1.2 Global Pediatric Influenza Treatment Market Size Market Share by Players (2017-2019)
- 3.2 Global Pediatric Influenza Treatment Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Pediatric Influenza Treatment by Regions
- 4.1 Pediatric Influenza Treatment Market Size by Regions
- 4.2 Americas Pediatric Influenza Treatment Market Size Growth
- 4.3 APAC Pediatric Influenza Treatment Market Size Growth
- 4.4 Europe Pediatric Influenza Treatment Market Size Growth
- 4.5 Middle East & Africa Pediatric Influenza Treatment Market Size Growth
5 Americas
- 5.1 Americas Pediatric Influenza Treatment Market Size by Countries
- 5.2 Americas Pediatric Influenza Treatment Market Size by Type
- 5.3 Americas Pediatric Influenza Treatment Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Pediatric Influenza Treatment Market Size by Countries
- 6.2 APAC Pediatric Influenza Treatment Market Size by Type
- 6.3 APAC Pediatric Influenza Treatment Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Pediatric Influenza Treatment by Countries
- 7.2 Europe Pediatric Influenza Treatment Market Size by Type
- 7.3 Europe Pediatric Influenza Treatment Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Pediatric Influenza Treatment by Countries
- 8.2 Middle East & Africa Pediatric Influenza Treatment Market Size by Type
- 8.3 Middle East & Africa Pediatric Influenza Treatment Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Pediatric Influenza Treatment Market Forecast
- 10.1 Global Pediatric Influenza Treatment Market Size Forecast (2019-2024)
- 10.2 Global Pediatric Influenza Treatment Forecast by Regions
- 10.2.1 Global Pediatric Influenza Treatment Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Pediatric Influenza Treatment Forecast by Type
- 10.8 Global Pediatric Influenza Treatment Forecast by Application
11 Key Players Analysis
- 11.1 F. Hoffmann-La Roche Ltd
- 11.1.1 Company Details
- 11.1.2 Pediatric Influenza Treatment Product Offered
- 11.1.3 F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 F. Hoffmann-La Roche Ltd News
- 11.2 GlaxoSmithKline Plc.
- 11.2.1 Company Details
- 11.2.2 Pediatric Influenza Treatment Product Offered
- 11.2.3 GlaxoSmithKline Plc. Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 GlaxoSmithKline Plc. News
- 11.3 NATCO Pharma Limited.
- 11.3.1 Company Details
- 11.3.2 Pediatric Influenza Treatment Product Offered
- 11.3.3 NATCO Pharma Limited. Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 NATCO Pharma Limited. News
- 11.4 NESHER PHARMS
- 11.4.1 Company Details
- 11.4.2 Pediatric Influenza Treatment Product Offered
- 11.4.3 NESHER PHARMS Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 NESHER PHARMS News
- 11.5 Johnson & Johnsons Inc.
- 11.5.1 Company Details
- 11.5.2 Pediatric Influenza Treatment Product Offered
- 11.5.3 Johnson & Johnsons Inc. Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Johnson & Johnsons Inc. News
- 11.6 Cipla
- 11.6.1 Company Details
- 11.6.2 Pediatric Influenza Treatment Product Offered
- 11.6.3 Cipla Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Cipla News
- 11.7 Hetero Pharma
- 11.7.1 Company Details
- 11.7.2 Pediatric Influenza Treatment Product Offered
- 11.7.3 Hetero Pharma Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Hetero Pharma News
- 11.8 Teva Pharmaceutical pvt. Ltd.
- 11.8.1 Company Details
- 11.8.2 Pediatric Influenza Treatment Product Offered
- 11.8.3 Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Teva Pharmaceutical pvt. Ltd. News
- 11.9 Olainfarm JSC
- 11.9.1 Company Details
- 11.9.2 Pediatric Influenza Treatment Product Offered
- 11.9.3 Olainfarm JSC Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Olainfarm JSC News
- 11.10 Gilead Sciences, Inc.
- 11.10.1 Company Details
- 11.10.2 Pediatric Influenza Treatment Product Offered
- 11.10.3 Gilead Sciences, Inc. Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Gilead Sciences, Inc. News
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Pediatric Influenza Treatment . Industry analysis & Market Report on Pediatric Influenza Treatment is a syndicated market report, published as Global Pediatric Influenza Treatment Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Pediatric Influenza Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
